$Ultragenyx Pharma(RARE.US) | Guggenheim ๐บ๐ฎ๐ถ๐ป๐๐ฎ๐ถ๐ป๐ ๐๐๐ on ๐จ๐น๐๐ฟ๐ฎ๐ด๐ฒ๐ป๐๐ ๐ฃ๐ต๐ฎ๐ฟ๐บ๐ฎ, cuts PT to $๐ฏ๐ฑ from $๐ฐ๐ฏ
Analyst sees a binary ASPIRE outcome, with overwhelming success driving $55โ$65 and failure sending RARE to the low teens.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments